Safety and immunogenicity of a live attenuated intranasal vaccine against respiratory syncytial virus in healthy RSV seronegative children 5 to 24 months of age.

E Malkin, R Yogev, N Abughali, J Sliman, K Wang, F Zuo, C Yang, M Eickoff, M Esser, R Tang, F Dubovsky

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)77104
Number of pages1
JournalPLoS ONE
Volume8
Issue number10
StatePublished - 2013

Cite this